Green Therapeutics is a cannabis company that manufactures and distributes dabs, vape pens, cartridges, oral sprays and topical creams. Read more

Green Therapeutics is a cannabis company that manufactures and distributes dabs, vape pens, cartridges, oral sprays and topical creams. Read more

Duke Fu's photo - CEO of Green Therapeutics

CEO

Duke Fu

CEO Approval Rating

70/100

Founded:

2014

Status:

PrivateAcquisition Pending from Australis Capital, Inc.

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Emerald Health is seen as one of Green Therapeutics's biggest rivals. Emerald Health is headquartered in Victoria, British Columbia, and was founded in 2007. Emerald Health competes in the Health Care Supplies field. Emerald Health generates 1,153% the revenue of Green Therapeutics.

Supreme Cannabis is seen as one of Green Therapeutics's top competitors. Supreme Cannabis was founded in 1979, and its headquarters is in Toronto, Ontario. Supreme Cannabis operates in the Life Sciences industry. Supreme Cannabis has 340 more employees than Green Therapeutics.

Canndescent is one of Green Therapeutics's top rivals. Canndescent is a Private company that was founded in Santa Barbara, California in 2015. Canndescent competes in the Health Care Supplies industry. Canndescent has 140 more employees vs. Green Therapeutics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is WeedMD a competitor of Green Therapeutics?

Acquisitions

No recent acquisitions found related to Green Therapeutics

Green Therapeutics Funding History

$150K

Since Green Therapeutics was founded in 2014, it has participated in 1 round of funding. In total Green Therapeutics has raised $150.0K. Green Therapeutics' funding round was on May 2020 for a total of $150.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
May 2020
$150K - $350K

U.S. Small Business Administration.

Since Green Therapeutics was founded in 2014, it has participated in 1 round of funding. In total Green Therapeutics has raised $150.0K. Green Therapeutics' funding round was on May 2020 for a total of $150.0K

Investments

No recent investments found related to Green Therapeutics

Green Therapeutics News

June 29, 2020Benzinga

Green Therapeutics LLC and Meridian Companies LLC Commence Formal Legal Action Against Australis Capital Inc. and Certain of its Affiliates for Breach of Contract

TORONTO, June 30, 2020 /CNW/ - Green Therapeutics LLC and Meridian Companies LLC (together referred t... See more »
May 21, 2019Silver Investing News

Nutritional High Cuts Green Therapeutics Purchase Price in Half; Green Therapeutics to Divest Non-Core Assets

Nutritional High (CSE:EAT, OTCQB:SPLIF, FWB:2NU) is pleased to announce it has entered into an agreem... See more »
December 7, 2018Silver Investing News

Nutritional High Delighted by Grant of Conditional Approval of Green Therapeutics' Dispensary License in Nevada

Nutritional High (CSE:EAT, OTCQB:SPLIF, FWB:2NU) is pleased to announce that the Nevada-based Green T... See more »

Green Therapeutics Press Releases

November 22, 2018CentralCharts

Nutritional High Acquires Controlling Interest in One of California's Leading Edibles Company and Bolsters Product Offering

Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE: EAT, OTCQB: SPLIF, FR... See more »
October 1, 2018GlobalNewswire

Nutritional High Enters Into Definitive Agreements to Complete Previously Announced Acquisition of Green Therapeutics in Nevada

TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nut... See more »

Social Media

Headquarters

7250 S. Durango Drive Suite 130

Las Vegas, Nevada89113

775-372-7505

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Green Therapeutics is a cannabis company that manufactures and distributes dabs, vape pens, cartridges, oral sprays and topical creams. Green Therapeutics was founded in 2014. Green Therapeutics' headquarters is located in Las Vegas, Nevada, USA 89113...

CEO

Green Therapeutics's CEO, Duke Fu, currently has an approval rating of 70%. Green Therapeutics's primary competitors are Emerald Health, Supreme Cannabis & Canndescent.

Website

gtnevada.com

Frequently Asked Questions about Green Therapeutics

  1. When was Green Therapeutics founded?

    Green Therapeutics was founded in 2014
  2. Who is Green Therapeutics's CEO?

    Green Therapeutics's CEO is Duke Fu
  3. How much revenue does Green Therapeutics generate?

    Green Therapeutics generates $5M in revenue
  4. How much funding does Green Therapeutics have?

    Green Therapeutics has historically raised $150K in funding
  1. Where is Green Therapeutics's headquarters?

    Green Therapeutics's headquarters is in Las Vegas Nevada, USA
  2. How many employees does Green Therapeutics have?

    Green Therapeutics has 60 employees
  3. What sector does Green Therapeutics operate in?

    Green Therapeutics is in Health Care Services
  4. Who are Green Therapeutics's competitors?

    Green Therapeutics's top competitors are Emerald Health, Supreme Cannabis, Canndescent